Herpes simplex, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares.
High-dose, short-duration, early valacyclovir therapy for episodic
treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies
>Abstract
>Full Text
Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis
>Abstract
>Full Text
Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials
>Abstract
>Full Text(>Arch Virol.)
LongoVital and herpes labialis: a randomised, double-blind, placebo-controlled study
>Abstract
>Full Text(>Oral Dis.)
Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream,
acyclovir cream, and n-docosanol cream against
experimental cutaneous herpes simplex virus type 1 infection
>Abstract
>Full Text(>Arch Dermatol.)
Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis
>Abstract(>Phytomedicine.)
Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey
>Free Full Text(>J Antimicrob Chemother.)
Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial
>Abstract
>Full Text(>Br J Dermatol.)
